About this episode
Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no serious side effects in a clinical trial. The anchors explored the push to develop and ...
Up next
Nov 20
Tech Sell-Off Deepens as AI, Cyber Risk and China Chip Rules Shake Markets
November 20, 2026; 11am: Squawk on the Street tracks a deepening tech sell-off, Anthropic’s volatile post-IPO trade and Nasdaq losses as investors weigh AI valuations, Fed risk and data center concerns. Guests also break down cyber outages, U.S.-China chip export rules and Bath & ...
40m 34s
Oct 28
11AM Hour: JLL CEO, Generac CEO & Big Tech Earnings on Deck 10/28/26
JLL CEO Christian Ulbrich joins to discuss the firm's record results and the health of the commercial real estate sector. Then, Generac CEO Aaron Jagdfeld breaks down their quarterly results as the stock has a volatile morning. Plus, D.A. Davidson's Gil Luria shares his expectati ...
43m 6s
Recommended Episodes
Nov 2020
A Vaccine Boost
Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason ...
39m 10s
May 2021
Pfizer’s Results, What’s Next for Retail & Restaurants, The High Bar for CRISPR & More
<p>It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ...
58m 18s
Aug 2021
U.S. To Urge Covid-19 Booster Shots
Michael Dowling, CEO at Northwell Health, discusses the U.S. government expected to recommend booster shots eight months after people get their second vaccine dose. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Deals Reporter Scott Deveau talk about how the SPAC boo ...
35m 26s
Jul 2023
On Holding Co-CEO, Paychex CEO & A Starry Quarter For Constellation? 7/5/23
<p>All three averages slipped and Jim Cramer is helping investors navigate market volatility in this holiday-shortened week. First, On opened its newest location in Williamsburg last week and Cramer is sitting down with co-CEO Martin Hoffmann at the Brooklyn flagship to learn mor ...
45m 25s
Jan 2021
As GameStop Turns
Investors react to the escalating drama with Redditt, speculators, and GameStop. Johnson & Johnson reports Phase 3 trial results from its one-shot vaccine. Apple reports record-breaking revenue. Microsoft hits a new high on earnings. Facebook slides. Atlassian rises. Starbucks su ...
39m 10s
Aug 2021
U.S. To Offer Covid-19 Boosters in September
Dr. William Haseltine, Chair and President of Access Health International, discusses the Biden administration offering Covid boosters starting in late September. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Finance Reporter Sri Natarajan talk about Wall Street brin ...
36m 5s
Aug 2021
SEC to Demand More Transparency From China
Dr. Vino Palli, CEO of MiDoctor Urgent Care, discusses the Covid virus and vaccinations. Businessweek Technology Editor Joshua Brustein talks about his Businessweek Magazine story Afghanistan War Turns a U.S. Military Startup Into a Unicorn. Bloomberg News Financial Regulations R ...
42m 46s
May 2021
Dow Surged 238 Points, GXO Logistics CEO & Lydall CEO
The Dow started the week in the green, up 238 points and Cramer’s taking you through the market action and where you might spot opportunity. Then, Cramer’s talking to Malcolm Wilson, the incoming CEO of GXO Logistics – a spinoff of XPO Logistics – to hear more about this latest v ...
44m 42s
Dec 2021
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...
38m 7s
Jul 2023
DocuSign CEO, Sprinklr CEO & IRA Winners 7/12/23
<p>Stocks rose, with the S&P 500 and Nasdaq closing at their highest levels since April 2022, and Jim Cramer is breaking down today's market moves. First, Cramer's checking in on pandemic play DocuSign to see how the company is faring with CEO Allan Thygesen. Then, could a sprink ...
45m 20s